J. Bertet

Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis

Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage

Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive

Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography

Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

The NAFLD fibrosis score

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Non-alcoholic fatty liver disease

Crohn's disease

Mechanisms of Hepatic Fibrogenesis

Risk Assessment of Hepatocellular Carcinoma in Chronic Hepatitis C Patients by Transient Elastography

Transient Elastography for the Noninvasive Assessment of Liver Fibrosis: A Multicentre Canadian Study

Hepatitis C: global epidemiology and strategies for control

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease

Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Non-invasive evaluation of liver fibrosis using transient elastography

Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations

Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C

Noninvasive assessment of fibrosis and steatosis in NASH and ASH

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

EASL Recommendations on Treatment of Hepatitis C 2018

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

The Controversial Role of Human Gut Lachnospiraceae

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

Noninvasive diagnosis of nonalcoholic fatty liver disease

Ultrasound Elastography: Review of Techniques and Clinical Applications

Nonalcoholic Fatty Liver Disease

Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations

Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: Long-term follow-up of 196 patients (4535 patient-years)

Diagnosis of liver fibrosis by transient elastography (FibroScan) and non‐invasive methods in Crohn's disease patients treated with methotrexate